These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2537237)

  • 1. Significance of incisional biopsy in breast carcinoma: results from a clinical trial with intended excisional biopsy.
    Watt-Boolsen S; Ottesen G; Andersen JA; Bayer T; Jespersen NC; Keiding N; Mouridsen HT; Dombernowsky P; Blichert-Toft M
    Eur J Surg Oncol; 1989 Feb; 15(1):33-7. PubMed ID: 2537237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of occult invasive breast cancer after excisional biopsy showing in-situ ductal carcinoma of comedo pattern.
    Hardman PD; Worth A; Lee U; Baird RM
    Can J Surg; 1989 Jan; 32(1):56-60. PubMed ID: 2535949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late recurrence of ductal carcinoma in situ at the cutaneous end of surgical drainage following total mastectomy.
    Finkelstein SD; Sayegh R; Thompson WR
    Am Surg; 1993 Jul; 59(7):410-4. PubMed ID: 8391769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
    Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
    Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
    Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
    Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer.
    Katz A; Gage I; Evans S; Shaffer M; Fleury T; Smith FP; Flax R; Drogula C; Petrucci P; Magnant C
    Am J Surg; 2006 Jun; 191(6):761-6. PubMed ID: 16720145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wide excision of primary breast cancer: the incidence of residual carcinoma at the site of excision.
    Umpleby HC; Herbert A; Royle GT; Taylor I
    Ann R Coll Surg Engl; 1988 Jul; 70(4):246-8. PubMed ID: 2843075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary recurrence in DCIs: is axillary lymphadenectomy warranted?
    Trisal V; Qian D; Wagman LD
    Am Surg; 2004 Oct; 70(10):876-80. PubMed ID: 15529841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.
    Hiramatsu H; Bornstein BA; Recht A; Schnitt SJ; Baum JK; Connolly JL; Duda RB; Guidi AJ; Kaelin CM; Silver EB; Harris JR
    Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult "micrometastases" in ductal carcinoma in situ: investigative implications for sentinel lymph node biopsy.
    Weaver DL
    Cancer; 2003 Nov; 98(10):2083-7. PubMed ID: 14601075
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.